“We were thrilled to honor these prominent women leaders, not only because of their individual achievements, but because of what their presence represents. It is undeniable that there is an abundance of talented and highly capable women leaders, yet women continue to be severely underrepresented on boards and in the senior leadership of public companies,” stated Michellene Davis, Esq., president of EWNJ and EVP and chief corporate affairs officer of RWJBarnabas Health. “That’s why we highlight these trailblazers to showcase the impact of women’s leadership and to continue to spotlight the issue of corporate gender diversity.”
Judith Sheft stated, “I’m honored to be recognized by Executive Women of New Jersey. It is important that women have equal opportunity and representation in senior corporate and institutional leadership and are recognized for their achievements. Among other vital initiatives I fully support the work of EWNJ and its focus on teaching and mentoring underrepresented minorities in academic programs.”
Founded in 1980, EWNJ is the leading senior-level executive women’s organization that is committed to increasing the presence of women serving on corporate boards and in the top leadership of New Jersey companies. To this end, it publishes a biennial report on the number of women on boards and in the senior governance of public companies in New Jersey. This report is the only one of its kind in the state. EWNJ also hosts an array of events designed to offer women executives prime networking opportunities, to amplify gender diversity advocacy efforts, and to raise funds for its Graduate Merit Award Program, which is focused on establishing a pipeline of future leaders.
The New Jersey Innovation Institute (NJII) is an NJIT corporation that applies the intellectual and technological resources of the state’s science and technology university to challenges identified by industry partners. Through its Innovation Labs (iLabs), NJII brings NJIT expertise to key economic sectors, including healthcare delivery systems, bio-pharmaceutical production, civil infrastructure, defense and homeland security, and financial services.